Steakholder Foods Begins Bovine Cell Line Development Activity in the United States Using USDA-Approved Cattle
Steakholder Foods Ltd. (Nasdaq: STKH) has initiated the development of a bovine cell line in the US, utilizing cells from USDA-approved cattle. This move is part of the company's strategy to align with regulatory standards as it seeks approval for cultured meat products in the US. The USDA will play a key role in this process, with Steakholder ensuring the health and quality of the sourced cells. CEO Arik Kaufman expressed enthusiasm about this advancement, highlighting the company's commitment to safety and quality in sustainable meat production.
- Commencement of bovine cell line development enhances regulatory compliance for product approval in the US.
- Collaboration with USDA-approved farms ensures quality, potentially increasing consumer trust.
- Aims to produce cultured meat, positioning the company as a frontrunner in sustainable food production.
- Significant work remains before potential commercial sales of cultured meat can begin.
- Dependence on regulatory approval introduces uncertainty in the timeline for market entry.
The use of an agency-approved animal source for the company's cell line is part of the Company's regulatory strategy ahead of the planned approval process in the USA.
REHOVOT, Israel, Sept. 28, 2022 /PRNewswire/ -- Steakholder Foods Ltd. (Nasdaq: STKH), (formerly MeaTech 3D: $MITC) an international deep-tech food company at the forefront of the cultured meat industry, today announced that it has commenced development of a bovine cell line in the US, isolating cells sourced from live cattle raised on a farm approved by the United States Department of Agriculture (USDA).
The USDA is expected to be play a central role in approving cultured meat. In accordance with the regulatory guidelines published by the USDA and FSIS, Steakholder Foods is ensuring that the tissue samples that it collects are properly vetted and sourced from healthy animals, all as part of the company's aim of meeting the strict regulatory standards for approval in the U.S.
Steakholder Foods is extracting the cells from USDA-approved sources with the aim of producing edible products in a sterile environment in order to ensure the aseptic conditions required for food safety.
Arik Kaufman, Steakholder Foods Co-Founder and CEO: "We are excited that our latest cell development activity is moving the company forward on its path toward regulation. By working with USDA-approved farms and animals, Steakholder Foods is demonstrating its commitment to quality and safety. We aim to work with federal agencies as we perfect our processes for sustainable and scalable cultured meat production."
About Steakholder Foods
Steakholder Foods Ltd., formerly MeaTech 3D Ltd., is an international deep-tech food company at the forefront of the cultured meat revolution. The company initiated activities in 2019 and is listed on the Nasdaq Capital Market under the ticker "STKH" (formally MITC). Steakholder Foods maintains facilities in Rehovot, Israel and Antwerp, Belgium and has recently expanded activities to the US.
The company is developing a slaughter-free solution for producing a variety of beef, chicken, pork, and seafood products — both as raw materials and whole cuts — as an alternative to industrialized farming and fishing. With its membership in the UN Global Compact, Steakholder Foods is committed to act in support of issues embodied in the United Nations Sustainable Development Goals (SDGs) include strengthening food security, decreasing carbon footprint, and conserving water and land resources. For more information, please visit: https://steakholderfoods.com
Forward-Looking Statements
This press release contains forward-looking statements concerning Steakholder Foods' business, operations and financial performance and condition as well as plans, objectives, and expectations for Steakholder Foods' business operations and financial performance and condition. Any statements that are not historical facts may be deemed to be forward-looking statements. Forward-looking statements reflect Steakholder Foods' current views with respect to future events and are based on assumptions and subject to known and unknown risks and uncertainties, which change over time, and other factors that may cause Steakholder Food's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and are typically identified with words such as "may," "could," "should," "will," "would," "believe," "anticipate," "estimate," "expect," "aim," "intend," "plan" or words or phases of similar meaning and include, without limitation, Steakholder Foods' expectations regarding the success of its cultured meat manufacturing technologies it is developing, which will require significant additional work before Steakholder Foods can potentially launch commercial sales; Steakholder Foods' research and development activities associated with technologies for cultured meat manufacturing, including three-dimensional meat production, which involves a lengthy and complex process; Steakholder Foods' ability to obtain and enforce its intellectual property rights and to operate its business without infringing, misappropriating, or otherwise violating the intellectual property rights and proprietary technology of third parties; and other risks and uncertainties, including those identified in Steakholder Foods' Annual Report on Form 20-F for the fiscal year ended December 31, 2021, filed with the Securities and Exchange Commission on March 24, 2022. New risks and uncertainties may emerge from time to time, and it is not possible for Steakholder Foods to predict their occurrence or how they will affect Steakholder Foods. If one or more of the factors affecting Steakholder Foods' forward-looking information and statements proves incorrect, then Steakholder Foods' actual results, performance or achievements could differ materially from those expressed in, or implied by, forward-looking information and statements contained in this press release. Therefore, Steakholder Foods cautions you not to place undue reliance on its forward-looking information and statements. Steakholder Foods disclaims any duty to revise or update the forward-looking statements, whether written or oral, to reflect actual results or changes in the factors affecting the forward-looking statements, except as specifically required by law.
Steakholder Foods Press Contact: | Steakholder Investor Contacts: | |
Maissa Dauriac Rainier Communications mdauriac@rainierco.com | Joseph Green Edison Group jgreen@edisongroup.com | Ehud Helft Edison Israel ehelft@edisongroup.com |
Logo:https://mma.prnewswire.com/media/1871733/Steakholder_Foods_Ltd_logo.jpg
View original content:https://www.prnewswire.com/news-releases/steakholder-foods-begins-bovine-cell-line-development-activity-in-the-united-states-using-usda-approved-cattle-301635336.html
SOURCE MeaTech 3D
FAQ
What is Steakholder Foods' recent development in the US?
When was the announcement made about Steakholder Foods' bovine cell line development?
What role does the USDA play in Steakholder Foods' operations?
What is the stock symbol for Steakholder Foods?
What are the potential market impacts of Steakholder Foods' new cell line development?
